brexpiprazole Alzheimer agitation
Selected indexed studies
- Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study. (Alzheimers Dement, 2024) [PMID:39369280]
- Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial. (JAMA Neurol, 2023) [PMID:37930669]
- Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials. (Neurol Sci, 2024) [PMID:38763935]
_Worker-drafted node — pending editorial review._
Connections
brexpiprazole Alzheimer agitation is a side effect of
Sources
- Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study. (2024) pubmed
- Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial. (2023) pubmed
- Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials. (2024) pubmed
- Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease. (2024) pubmed
- Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials. (2020) pubmed
- Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia. (2025) pubmed
- Brexpiprazole for agitation in alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials. (2025) pubmed
- Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial. (2024) pubmed
- Brexpiprazole: Pioneering medication for managing agitation in Alzheimer's disease. (2025) pubmed
- Brexpiprazole for the Treatment of Agitation in Older Adults with Alzheimer's Disease: A Systematic Review, Bayesian Meta-analysis, and Meta-regression. (2025) pubmed